This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: 3D Signatures Holdings Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Macoura Gadji: Innovator in Hematological Disorder Diagnosis
Introduction
Macoura Gadji is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of hematology through his innovative patent. His work focuses on improving the diagnosis of hematological disorders, which can greatly enhance patient outcomes.
Latest Patents
Macoura Gadji holds a patent titled "Hematological disorder diagnosis by 3D q-FISH." This patent provides methods for prognosing a clinical outcome in a subject with a hematological disorder. The methods involve determining a 3D telomeres organization signature of a test sample cell from the subject. This signature is indicative of the clinical outcome of the subject, showcasing the potential for improved diagnostic techniques in hematology. He has 1 patent to his name.
Career Highlights
Throughout his career, Macoura has worked with various companies that focus on innovative technologies in the medical field. Notably, he has been associated with 3D Signatures Holdings Inc. and Telo Genomics Holdings Corp. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to advancements in hematological research.
Collaborations
Macoura Gadji has collaborated with esteemed colleagues such as Sabine Mai and Hans Knecht. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the medical community.
Conclusion
Macoura Gadji's contributions to the diagnosis of hematological disorders through his innovative patent demonstrate his commitment to improving patient care. His work exemplifies the importance of innovation in the medical field, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile